BioNexus Gene Lab Corp (BGLC) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $7.42M | -21.9% |
| 2024 | $9.51M | -2.7% |
| 2023 | $9.77M | -10.6% |
| 2022 | $10.93M | -18.2% |
| 2021 | $13.36M | +17.3% |
| 2020 | $11.39M | +8872.0% |
| 2019 | $127.0K | -40.2% |
| 2018 | $212.3K | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $7.42M | -21.9% |
| 2024 | $9.51M | -2.7% |
| 2023 | $9.77M | -10.6% |
| 2022 | $10.93M | -18.2% |
| 2021 | $13.36M | +17.3% |
| 2020 | $11.39M | +8872.0% |
| 2019 | $127.0K | -40.2% |
| 2018 | $212.3K | — |